Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. These changes reflect the page's version history rather than any modification to study details or eligibility.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Locations section with California and Georgia, reorganizing location information. Removed the HHS Vulnerability Disclosure link and updated the revision to v3.3.3.SummaryDifference0.3%

- Check52 days agoChange DetectedRevision information on the page was updated to v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding lapse notice about NIH Clinical Center operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe new screenshot shows only minor UI changes and a refreshed 'Last Update' date; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check102 days agoChange DetectedMajor update: adds a government-status notice and a new version tag (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference4%

Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.